Birdwatch Note
2024-10-02 07:21:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
コロナワクチン接種ががんのリスクになる事は米国立がん研究所にも把握されていません https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer# ワクチンで免疫低下等の話も専門家にも知られていません https://apnews.com/article/fact-check-australia-study-vaccine-immunodeficiency-vaids-188567674141 https://factcheck.afp.com/doc.afp.com.34977JH がんの年間登録数は下記図3に公表され、検診減少等の影響もあるでしょうが、コロナ前の増加傾向より大幅に少なくなっています https://www.ncc.go.jp/jp/information/pr_release/2024/0125_1/index.html その他、免疫不全や低下指標として使われる疾患のうち記録があるものとして https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou11/01-05-07.html 帯状疱疹も21年,22年にコロナ前より減少しています(下記２つめの図 https://web.archive.org/web/20230725185950/https://news.yahoo.co.jp/articles/6ca1c6739b46d8201f28467a56bfd773cc2332af 活動性結核は昨年ウィズコロナとともに前年比で１２人の増加がみられましたがそれでも１９年より３割少ない患者数となっています(下記29p https://www.mhlw.go.jp/content/10900000/001295037.pdf#page=29
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1841338939480924601
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1841377875267919950
- noteId - 1841377875267919950
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1727853671268
- tweetId - 1841338939480924601
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- コロナワクチン接種ががんのリスクになる事は米国立がん研究所にも把握されていません https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer# ワクチンで免疫低下等の話も専門家にも知られていません https://apnews.com/article/fact-check-australia-study-vaccine-immunodeficiency-vaids-188567674141 https://factcheck.afp.com/doc.afp.com.34977JH がんの年間登録数は下記図3に公表され、検診減少等の影響もあるでしょうが、コロナ前の増加傾向より大幅に少なくなっています https://www.ncc.go.jp/jp/information/pr_release/2024/0125_1/index.html その他、免疫不全や低下指標として使われる疾患のうち記録があるものとして https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou11/01-05-07.html 帯状疱疹も21年,22年にコロナ前より減少しています(下記２つめの図 https://web.archive.org/web/20230725185950/https://news.yahoo.co.jp/articles/6ca1c6739b46d8201f28467a56bfd773cc2332af 活動性結核は昨年ウィズコロナとともに前年比で１２人の増加がみられましたがそれでも１９年より３割少ない患者数となっています(下記29p https://www.mhlw.go.jp/content/10900000/001295037.pdf#page=29
Note Ratings
| rated at | rated by | |
| 2024-10-02 19:54:09 -0500 | Rating Details | |
| 2024-10-02 19:38:54 -0500 | Rating Details | |
| 2024-10-02 19:22:35 -0500 | Rating Details | |
| 2024-10-02 18:59:14 -0500 | Rating Details | |
| 2024-10-02 18:30:06 -0500 | Rating Details | |
| 2024-10-02 18:29:17 -0500 | Rating Details | |
| 2024-10-02 18:10:32 -0500 | Rating Details | |
| 2024-10-02 17:45:05 -0500 | Rating Details | |
| 2024-10-02 17:10:04 -0500 | Rating Details | |
| 2024-10-02 16:59:30 -0500 | Rating Details | |
| 2024-10-02 16:35:52 -0500 | Rating Details | |
| 2024-10-02 15:54:23 -0500 | Rating Details | |
| 2024-10-02 15:26:35 -0500 | Rating Details | |
| 2024-10-02 14:38:03 -0500 | Rating Details | |
| 2024-10-02 13:25:34 -0500 | Rating Details | |
| 2024-10-02 12:37:46 -0500 | Rating Details | |
| 2024-10-02 11:13:16 -0500 | Rating Details | |
| 2024-10-02 11:08:12 -0500 | Rating Details | |
| 2024-10-02 10:46:36 -0500 | Rating Details | |
| 2024-10-02 10:12:18 -0500 | Rating Details | |
| 2024-10-02 10:01:43 -0500 | Rating Details | |
| 2024-10-02 09:51:32 -0500 | Rating Details | |
| 2024-10-02 09:28:04 -0500 | Rating Details | |
| 2024-10-02 09:25:18 -0500 | Rating Details | |
| 2024-10-02 09:09:54 -0500 | Rating Details | |
| 2024-10-02 09:01:28 -0500 | Rating Details | |
| 2024-10-02 08:48:13 -0500 | Rating Details | |
| 2024-10-02 08:42:43 -0500 | Rating Details | |
| 2024-10-02 08:39:06 -0500 | Rating Details | |
| 2024-10-02 08:31:45 -0500 | Rating Details | |
| 2024-10-02 08:23:39 -0500 | Rating Details | |
| 2024-10-02 08:21:16 -0500 | Rating Details | |
| 2024-10-02 08:09:26 -0500 | Rating Details | |
| 2024-10-02 08:03:52 -0500 | Rating Details | |
| 2024-10-02 08:00:41 -0500 | Rating Details | |
| 2024-10-02 07:59:04 -0500 | Rating Details | |
| 2024-10-02 07:51:30 -0500 | Rating Details | |
| 2024-10-02 07:46:56 -0500 | Rating Details | |
| 2024-10-02 07:45:32 -0500 | Rating Details | |
| 2024-10-02 07:42:29 -0500 | Rating Details | |
| 2024-10-02 07:31:08 -0500 | Rating Details | |
| 2024-10-02 07:30:57 -0500 | Rating Details | |
| 2024-10-02 07:27:32 -0500 | Rating Details | |
| 2024-10-02 07:26:09 -0500 | Rating Details | |
| 2024-10-02 07:25:54 -0500 | Rating Details | |
| 2024-10-02 07:22:13 -0500 | Rating Details | |
| 2024-10-02 07:20:08 -0500 | Rating Details | |
| 2024-10-02 07:11:07 -0500 | Rating Details | |
| 2024-10-02 07:09:53 -0500 | Rating Details | |
| 2024-10-02 07:01:24 -0500 | Rating Details | |
| 2024-10-02 06:55:35 -0500 | Rating Details | |
| 2024-10-02 06:53:45 -0500 | Rating Details | |
| 2024-10-02 06:45:14 -0500 | Rating Details | |
| 2024-10-02 06:25:24 -0500 | Rating Details | |
| 2024-10-02 06:23:17 -0500 | Rating Details | |
| 2024-10-02 06:15:14 -0500 | Rating Details | |
| 2024-10-02 06:09:54 -0500 | Rating Details | |
| 2024-10-02 06:08:22 -0500 | Rating Details | |
| 2024-10-02 05:51:30 -0500 | Rating Details | |
| 2024-10-02 05:51:23 -0500 | Rating Details | |
| 2024-10-02 05:50:25 -0500 | Rating Details | |
| 2024-10-02 05:47:34 -0500 | Rating Details | |
| 2024-10-02 05:44:47 -0500 | Rating Details | |
| 2024-10-02 05:44:12 -0500 | Rating Details | |
| 2024-10-02 05:24:56 -0500 | Rating Details | |
| 2024-10-02 05:01:59 -0500 | Rating Details | |
| 2024-10-02 04:49:53 -0500 | Rating Details | |
| 2024-10-02 04:49:45 -0500 | Rating Details | |
| 2024-10-02 04:48:38 -0500 | Rating Details | |
| 2024-10-02 04:32:27 -0500 | Rating Details | |
| 2024-10-02 04:32:25 -0500 | Rating Details | |
| 2024-10-02 04:22:13 -0500 | Rating Details | |
| 2024-10-02 04:12:06 -0500 | Rating Details | |
| 2024-10-02 04:05:41 -0500 | Rating Details | |
| 2024-10-02 04:04:19 -0500 | Rating Details | |
| 2024-10-02 04:00:48 -0500 | Rating Details | |
| 2024-10-02 03:58:42 -0500 | Rating Details | |
| 2024-10-02 03:42:38 -0500 | Rating Details | |
| 2024-10-02 03:27:31 -0500 | Rating Details | |
| 2024-10-02 03:21:07 -0500 | Rating Details | |
| 2024-10-02 03:15:18 -0500 | Rating Details | |
| 2024-10-02 03:12:52 -0500 | Rating Details | |
| 2024-10-02 03:07:21 -0500 | Rating Details | |
| 2024-10-02 02:58:37 -0500 | Rating Details | |
| 2024-10-02 02:52:07 -0500 | Rating Details | |
| 2024-10-02 02:48:14 -0500 | Rating Details | |
| 2024-10-02 02:46:19 -0500 | Rating Details | |
| 2024-10-02 02:40:15 -0500 | Rating Details | |
| 2024-10-02 02:39:45 -0500 | Rating Details | |
| 2024-10-02 02:38:18 -0500 | Rating Details | |
| 2024-10-02 02:35:27 -0500 | Rating Details | |
| 2024-10-02 02:30:01 -0500 | Rating Details | |
| 2024-10-04 06:10:05 -0500 | Rating Details | |
| 2024-10-03 19:15:41 -0500 | Rating Details | |
| 2024-10-03 12:14:05 -0500 | Rating Details | |
| 2024-10-03 08:09:09 -0500 | Rating Details | |
| 2024-10-03 07:41:39 -0500 | Rating Details | |
| 2024-10-03 06:41:33 -0500 | Rating Details | |
| 2024-10-03 05:33:23 -0500 | Rating Details | |
| 2024-10-03 03:51:39 -0500 | Rating Details | |
| 2024-10-03 02:27:29 -0500 | Rating Details | |
| 2024-10-03 00:58:51 -0500 | Rating Details | |
| 2024-10-03 00:51:50 -0500 | Rating Details | |
| 2024-10-03 00:49:47 -0500 | Rating Details | |
| 2024-10-03 00:46:52 -0500 | Rating Details | |
| 2024-10-03 00:31:19 -0500 | Rating Details | |
| 2024-10-03 00:19:35 -0500 | Rating Details | |
| 2024-10-03 00:14:32 -0500 | Rating Details | |
| 2024-10-02 22:32:52 -0500 | Rating Details | |
| 2024-10-02 21:36:22 -0500 | Rating Details | |
| 2024-10-02 20:54:11 -0500 | Rating Details | |
| 2024-10-02 20:06:07 -0500 | Rating Details | |
| 2024-10-02 19:42:21 -0500 | Rating Details | |
| 2024-10-02 18:44:06 -0500 | Rating Details | |
| 2024-10-02 17:47:56 -0500 | Rating Details | |
| 2024-10-02 16:58:16 -0500 | Rating Details | |
| 2024-10-02 15:40:02 -0500 | Rating Details | |
| 2024-10-02 15:28:21 -0500 | Rating Details | |
| 2024-10-02 15:19:35 -0500 | Rating Details | |
| 2024-10-02 11:37:00 -0500 | Rating Details | |
| 2024-10-02 11:36:11 -0500 | Rating Details | |
| 2024-10-02 09:56:07 -0500 | Rating Details | |
| 2024-10-02 09:49:22 -0500 | Rating Details | |
| 2024-10-02 09:06:33 -0500 | Rating Details | |
| 2024-10-02 08:27:47 -0500 | Rating Details | |
| 2024-10-02 08:26:06 -0500 | Rating Details | |
| 2024-10-02 07:42:38 -0500 | Rating Details | |
| 2024-10-02 07:17:23 -0500 | Rating Details | |
| 2024-10-02 05:22:31 -0500 | Rating Details | |
| 2024-10-02 05:00:02 -0500 | Rating Details | |
| 2024-10-02 04:59:54 -0500 | Rating Details | |
| 2024-10-02 04:50:29 -0500 | Rating Details | |
| 2024-10-02 04:39:27 -0500 | Rating Details | |
| 2024-10-02 04:34:02 -0500 | Rating Details | |
| 2024-10-02 04:16:36 -0500 | Rating Details | |
| 2024-10-02 03:52:26 -0500 | Rating Details | |
| 2024-10-02 03:36:45 -0500 | Rating Details | |
| 2024-10-02 03:31:35 -0500 | Rating Details | |
| 2024-10-02 03:26:41 -0500 | Rating Details | |
| 2024-10-02 03:22:32 -0500 | Rating Details | |
| 2024-10-02 03:05:47 -0500 | Rating Details | |
| 2024-10-02 03:03:10 -0500 | Rating Details | |
| 2024-10-02 03:01:44 -0500 | Rating Details | |
| 2024-10-02 03:01:32 -0500 | Rating Details | |
| 2024-10-02 02:38:57 -0500 | Rating Details | |
| 2024-10-02 02:32:27 -0500 | Rating Details | |
| 2024-10-02 02:23:51 -0500 | Rating Details | |
| 2024-10-03 06:30:19 -0500 | Rating Details | |
| 2024-10-03 05:32:36 -0500 | Rating Details | |
| 2024-10-03 02:29:58 -0500 | Rating Details | |
| 2024-10-02 22:57:07 -0500 | Rating Details | |
| 2024-10-02 22:47:00 -0500 | Rating Details | |
| 2024-10-02 17:29:39 -0500 | Rating Details | |
| 2024-10-02 15:24:56 -0500 | Rating Details | |
| 2024-10-02 11:44:45 -0500 | Rating Details | |
| 2024-10-02 10:42:31 -0500 | Rating Details | |
| 2024-10-02 08:41:35 -0500 | Rating Details | |
| 2024-10-02 08:33:07 -0500 | Rating Details | |
| 2024-10-02 08:24:09 -0500 | Rating Details | |
| 2024-10-02 07:24:02 -0500 | Rating Details | |
| 2024-10-02 07:10:07 -0500 | Rating Details | |
| 2024-10-02 06:46:36 -0500 | Rating Details | |
| 2024-10-02 04:35:08 -0500 | Rating Details | |
| 2024-10-02 04:22:20 -0500 | Rating Details | |
| 2024-10-02 03:05:32 -0500 | Rating Details | |
| 2024-10-02 02:40:29 -0500 | Rating Details | |
| 2024-10-06 16:32:53 -0500 | Rating Details | |
| 2024-10-03 23:19:37 -0500 | Rating Details | |
| 2024-10-03 16:17:40 -0500 | Rating Details | |
| 2024-10-03 05:53:08 -0500 | Rating Details | |
| 2024-10-03 03:42:48 -0500 | Rating Details | |
| 2024-10-03 02:25:14 -0500 | Rating Details | |
| 2024-10-03 02:01:51 -0500 | Rating Details | |
| 2024-10-02 21:26:32 -0500 | Rating Details | |
| 2024-10-02 16:27:30 -0500 | Rating Details | |
| 2024-10-02 16:10:38 -0500 | Rating Details | |
| 2024-10-02 15:30:05 -0500 | Rating Details | |
| 2024-10-02 11:30:31 -0500 | Rating Details | |
| 2024-10-02 05:52:33 -0500 | Rating Details | |
| 2024-10-02 05:04:36 -0500 | Rating Details | |
| 2024-10-02 04:50:36 -0500 | Rating Details | |
| 2024-10-02 04:35:59 -0500 | Rating Details | |
| 2024-10-02 03:41:43 -0500 | Rating Details | |
| 2024-10-02 03:37:04 -0500 | Rating Details | |
| 2024-10-02 02:26:44 -0500 | Rating Details | |
| 2024-10-05 07:36:32 -0500 | Rating Details | |
| 2024-10-11 22:40:28 -0500 | Rating Details |